MIRA Pharmaceuticals Inc. (MIRA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    MIRA Pharmaceuticals Inc.

    NASDAQ: MIRA · Real-Time Price · USD
    1.31
    0.01 (0.77%)
    At close: Sep 26, 2025, 1:16 PM

    MIRA Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a 8.53M n/a n/a
    Gross Profit
    		 n/a -8.53M n/a n/a
    Operating Income
    		 -8.02M -8.53M -7.05M -2.15M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -7.85M -11.98M -7.06M -2.18M
    Net Income
    		 -7.85M -11.98M -7.06M -2.18M
    Selling & General & Admin
    		 4.71M 6.95M 2.99M 770.12K
    Research & Development
    		 3.31M 1.57M 2.35M 684.45K
    Other Expenses
    		 n/a 0.00 -1.7M -697.6K
    Operating Expenses
    		 8.02M 8.53M 7.05M 2.15M
    Interest Expense
    		 165.67K 3.46M 10.25K 24.37K
    Selling & Marketing Expenses
    		 n/a 453.55K n/a n/a
    Cost & Expenses
    		 n/a 8.53M 7.05M 2.15M
    Income Tax Expense
    		 n/a n/a -7.05K -2.15K
    Shares Outstanding (Basic)
    		 15.44M 18.57M 14.75M 14.75M
    Shares Outstanding (Diluted)
    		 15.44M 18.57M 14.75M 14.75M
    EPS (Basic)
    		 -0.51 -0.65 -0.48 -0.15
    EPS (Diluted)
    		 -0.51 -0.65 -0.48 -0.15
    EBITDA
    		 -7.85M n/a -7.05M -2.15M
    EBIT
    		 -7.69M -8.53M -7.05M -2.15M
    Depreciation & Amortization
    		 -165.67K 8.53M 7.05M 2.15M

    Add to Watchlist